ÂÜÀòÂÒÂ×

Brad Miles is an accomplished executive with extensive experience in the biotech and investment sectors. Serving as CEO and Co-Founder of Pike Therapeutics since September 2019, Brad has also held the position of President at LYL Holdings Inc. since October 2016, focusing on private equity investments in biotech and cannabinoids. Prior to these roles, Brad was a Senior Advisor at Opiant Pharmaceuticals Inc., where responsibilities included guiding the Board of Directors on business development efforts related to the development of NARCAN Nasal Spray. Earlier in their career, Brad was a Director at ScotiaMcLeod, ranking among the top investment advisors in Canada for over a decade and managing significant investment assets. Brad holds a Bachelor of Physical Education from Brock University, completed from 1984 to 1988.